Literature DB >> 16601352

Luteolin, a flavonoid, inhibits CD40 ligand expression by activated human basophils.

Toru Hirano1, Junsuke Arimitsu, Shinji Higa, Tetsuji Naka, Atsushi Ogata, Yoshihito Shima, Minoru Fujimoto, Tomoki Yamadori, Tomoharu Ohkawara, Yusuke Kuwabara, Mari Kawai, Ichiro Kawase, Toshio Tanaka.   

Abstract

BACKGROUND: We have previously shown that flavonoids such as luteolin, apigenin and fisetin inhibit interleukin 4 and interleukin 13 production. In this study, we investigated whether luteolin can suppress CD40 ligand expression by basophils.
METHODS: A human basophilic cell line, KU812, was stimulated with A23187 and phorbol myristate acetate (PMA) with or without various concentrations of luteolin or other flavonoids for 12 h, and CD40 ligand expression was analyzed by FACS. The effect of luteolin on CD40 ligand mRNA expression was studied by semiquantitative reverse transcription PCR analysis. In addition, CD40 ligand expression was also measured in purified basophils that had been stimulated for 12 h with A23187 plus PMA with or without various concentrations of luteolin.
RESULTS: CD40 ligand expression by KU812 cells was enhanced noticeably in response to A23187 and even more strikingly augmented by A23187 plus PMA. The expression was significantly suppressed by 10 or 30 microM of luteolin, whereas myricetin failed to inhibit. Reverse transcription PCR analyses demonstrated that luteolin inhibited CD40 ligand mRNA expression by stimulated KU812 cells. Of the six flavonoids examined, luteolin, apigenin, fisetin and quercetin at 30 microM showed a significant inhibitory effect on CD40 ligand expression. The incubation of purified basophils with A23187 plus PMA significantly enhanced CD40 ligand expression, and the presence of luteolin again had an inhibitory effect.
CONCLUSIONS: Luteolin inhibits CD40 ligand expression by activated basophils.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16601352     DOI: 10.1159/000092554

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  7 in total

Review 1.  Maternal immune activation and autism spectrum disorder: interleukin-6 signaling as a key mechanistic pathway.

Authors:  E Carla Parker-Athill; Jun Tan
Journal:  Neurosignals       Date:  2010-10-02

2.  Antimicrobial activity and synergism of some substituted flavonoids.

Authors:  M A Alvarez; N B Debattista; N B Pappano
Journal:  Folia Microbiol (Praha)       Date:  2008-05-15       Impact factor: 2.099

3.  Antiallergic effect of an aqueous leaf extract of Pistia stratiotes in murine model of ovalbumin-induced allergic conjunctivitis.

Authors:  Samuel Abokyi; George Asumeng Koffuor; Samuel Kyei; Emmanuel A Asiamah; Clement Nsobire Atobiga; Agnes Awuah
Journal:  Pharmacognosy Res       Date:  2014-10

Review 4.  Molecular mechanism underlying anti-inflammatory and anti-allergic activities of phytochemicals: an update.

Authors:  Yuva Bellik; Laïd Boukraâ; Hasan A Alzahrani; Balkees A Bakhotmah; Fatiha Abdellah; Si M Hammoudi; Mokrane Iguer-Ouada
Journal:  Molecules       Date:  2012-12-27       Impact factor: 4.411

5.  Hydrophilic Astragalin Galactoside Induces T Helper Type 1-Mediated Immune Responses via Dendritic Cells.

Authors:  Jae Hyoung Jeon; Byung-Cheol Lee; Doman Kim; Daeho Cho; Tae Sung Kim
Journal:  Int J Mol Sci       Date:  2018-10-11       Impact factor: 5.923

6.  Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression.

Authors:  Kavon Rezai-Zadeh; Jared Ehrhart; Yun Bai; Paul R Sanberg; Paula Bickford; Jun Tan; R Douglas Shytle
Journal:  J Neuroinflammation       Date:  2008-09-25       Impact factor: 8.322

Review 7.  Flavonoids and asthma.

Authors:  Toshio Tanaka; Ryo Takahashi
Journal:  Nutrients       Date:  2013-06-10       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.